0001437749-19-017333.txt : 20190823 0001437749-19-017333.hdr.sgml : 20190823 20190823063102 ACCESSION NUMBER: 0001437749-19-017333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190726 FILED AS OF DATE: 20190823 DATE AS OF CHANGE: 20190823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quertermous Thomas CENTRAL INDEX KEY: 0001647524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38999 FILM NUMBER: 191047078 MAIL ADDRESS: STREET 1: C/O BIOCARDIA INC STREET 2: 125 SHOREWAY ROAD SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 4 1 rdgdoc.xml FORM 4 X0306 4 2019-07-26 0000925741 BioCardia, Inc. BCDA;BCDAW 0001647524 Quertermous Thomas C/O BIOCARDIA, INC. 125 SHOREWAY ROAD, SUITE B SAN CARLOS CA 94070 1 Common Stock 2019-07-26 4 M 0 3594 0 A 15681 D Restricted Stock Units 0 2019-07-26 4 M 0 3594 0 D Common Stock 3594 0 D Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018. The converted RSU corresponds to a 1:1 common stock issuance. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4. /s/ David McClung, by power of attorney 2019-08-22